59 articles, transcripts, and reports
Thanks to the COVID-19 testing growth, after reporting solid second quarter results and strong outlook for fiscal 2020 last Thursday, shares of Abbott Laboratories (NYSE:…
Abbott Laboratories (NYSE: ABT) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President…
Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell 8% to b $7.3 billion,…
Abbott Laboratories (ABT) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing and Acquisitions Robert B. Ford — President…
Abbott Laboratories (NYSE: ABT) reported its financial results for the quarter ended March 31, 2020 today. The company reported a 16% drop in earnings for…
When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one industry that remained relatively resilient…
Abbott Laboratories (NYSE: ABT) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing and Acquisitions Miles D. White — Chairman…
Abbott Laboratories (NYSE: ABT) reported a marked increase in fourth-quarter earnings as the drugmaker’s strong product portfolio boosted sales in the key markets. The results…
Abbott Laboratories’ (NYSE: ABT) third quarter 2019 earnings came in line with the market’s projections, while sales missed the expectations. The pharma company reported adjusted…
